# A Study to Compare Two Different Tablet Formulations of AZD8931 in Healthy Males and Females

> **NCT01330758** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 26 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** AZD8931
- **DRUG:** AZD8931

## Key facts

- **NCT ID:** NCT01330758
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2011-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01330758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01330758, "A Study to Compare Two Different Tablet Formulations of AZD8931 in Healthy Males and Females". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01330758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*